Literature DB >> 10923645

Dopamine and serotonin VMN release is related to feeding status in obese and lean Zucker rats.

M M Meguid1, S O Fetissov, V Blaha, Z J Yang.   

Abstract

Study of neurotransmitter role in food intake regulation in a leptin signaling deficient model, such as the Zucker rat, would benefit in the understanding of mechanisms of human obesity, in which leptin resistance is a common syndrome. We studied dopamine (DA) and serotonin (5-HT) concentrations in vivo in the ventromedial nucleus (VMN) of the hypothalamus, as they relate to eating after food deprivation in obese and lean 9-week-old male Zucker rats. DA and 5-HT concentrations were measured by HPLC via microdialysis before and during refeeding in 24-h food-deprived rats. Before food was provided, mean baseline DA and 5-HT levels were lower in obese than in lean rats (9.2 +/- 0.9 vs 15.1 +/- 1.9 pg/10 microl, p < 0.01, and 0.68 +/- 0.05 vs 1.17 +/- 0.02 pg/10 microl, p < 0.001, respectively). Food intake was accompanied by a decrease in DA levels in both obese and lean rats to 64% (p < 0.01) and 65% (p < 0.02) of their baseline levels respectively. 5-HT levels were significantly increased during eating by 41% in obese and 35% in lean rats (p < 0.01) from the baseline levels. Thus in obese rats with altered leptin signaling we found an unaltered pattern of DA and 5-HT release associated with food deprivation and refeeding, but with presence of their low levels. This points to an impaired postsynaptic monoaminergic action to produce an adequate metabolic response in obese Zucker rats in response to feeding state.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923645     DOI: 10.1097/00001756-200007140-00002

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

Review 1.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Targeting the CNS to treat type 2 diabetes.

Authors:  Darleen A Sandoval; Silvana Obici; Randy J Seeley
Journal:  Nat Rev Drug Discov       Date:  2009-05       Impact factor: 84.694

3.  Imaging of brain dopamine pathways: implications for understanding obesity.

Authors:  Gene-Jack Wang; Nora D Volkow; Panayotis K Thanos; Joanna S Fowler
Journal:  J Addict Med       Date:  2009-03       Impact factor: 3.702

4.  Nasal administration of leptin dose-dependently increases dopamine and serotonin outflow in the rat nucleus accumbens.

Authors:  Sonya Neto; Ramya Varatharajan; Kevin Joseph; Andreas Moser
Journal:  J Neural Transm (Vienna)       Date:  2016-07-13       Impact factor: 3.575

5.  Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat.

Authors:  Anne Marie D Axel; Jens D Mikkelsen; Henrik H Hansen
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

6.  Local perfusion of mCPP into ventromedial hypothalamic nucleus, but not into lateral hypothalamic area and frontal cortex, inhibits food intake in rats.

Authors:  Katsuhito Hikiji; Koki Inoue; Shinichi Iwasaki; Kyuichiro Ichihara; Nobuo Kiriike
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

Review 7.  Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes.

Authors:  Ralph A Defronzo
Journal:  Diabetes Care       Date:  2011-04       Impact factor: 19.112

8.  Effect of high-fat feeding on expression of genes controlling availability of dopamine in mouse hypothalamus.

Authors:  Alex K Lee; Marjan Mojtahed-Jaberi; Theodosios Kyriakou; Estibaliz Aldecoa-Otalora Astarloa; Matthew Arno; Nichola J Marshall; Susan D Brain; Sandra D O'Dell
Journal:  Nutrition       Date:  2009-10-06       Impact factor: 4.008

9.  Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies.

Authors:  Fabio Panariello; Vincenzo De Luca; Andrea de Bartolomeis
Journal:  Schizophr Res Treatment       Date:  2010-12-06

10.  Cloning and functional characterization of the DA2 receptor gene in Chinese mitten crab (Eriocheir sinensis).

Authors:  Xiaozhen Yang; Genyong Huang; Min-Jie Xu; Cong Zhang; Yongxu Cheng; Zhigang Yang
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.